AIM: , and to analyze resistance genes using computational network for the identification of hub genes. METHODS: were screened for phenotypic detection of β-lactamase production and efflux pump overexpression, followed by genotypic identification of resistant determinants present among the isolates. The data from molecular characterization were integrated with computational network analysis, and the hub genes were identified. CONCLUSION: and proposes the identified hub genes as potential candidate genes for target-based drug development strategies to confront the emerging pathogen.
No takes yet. Share an insight, caveat, or question.
Gogoi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: